Hanako Ohmatsu Selected Research

Hanako Ohmatsu Research Topics

Disease

9	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 09/2015 - 12/2011
5	Neoplasms (Cancer) 01/2021 - 10/2012
5	Atopic Dermatitis (Atopic Eczema) 09/2014 - 05/2012
4	Inflammation (Inflammations) 01/2021 - 12/2010
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 08/2014
3	Mycosis Fungoides 01/2017 - 03/2013
3	Contact Dermatitis (Eczema, Contact) 06/2013 - 12/2010
3	Pruritus (Itching) 06/2013 - 05/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021
1	Erythema 01/2021
1	Pigmented Nevus (Melanocytic Nevus) 10/2016
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 06/2015
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 06/2015
1	Skin Diseases (Skin Disease) 09/2014
1	Disease Progression 09/2014
1	Infections 08/2014
1	Lymphoma (Lymphomas) 01/2014
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2014
1	Vitiligo 10/2013
1	Hematologic Neoplasms (Hematological Malignancy) 07/2012
1	Edema (Dropsy) 03/2012
1	Bacterial Infections (Bacterial Infection) 12/2011
1	HIV Infections (HIV Infection) 03/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2011
1	Hodgkin Disease (Hodgkin's Disease) 09/2010
1	Hypersensitivity (Allergy) 05/2009
1	Localized Scleroderma (Morphea) 11/2008

Drug/Important Bio-Agent (IBA)

3	Messenger RNA (mRNA)IBA 01/2017 - 08/2014
2	SteroidsIBA 01/2021 - 10/2012
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 09/2014
2	LigandsIBA 03/2013 - 01/2011
2	Irritants (Vesicants)IBA 03/2012 - 12/2010
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2017
1	Complementary DNA (cDNA)IBA 10/2016
1	Pancreatic Ribonuclease (Ribonuclease A)IBA 10/2016
1	Ribonucleases (Ribonuclease)IBA 10/2016
1	trichohyalinIBA 10/2016
1	Keratins (Keratin)IBA 10/2016
1	Aurora Kinase AIBA 09/2015
1	ParaffinIBA 06/2015
1	mogamulizumabIBA 06/2015
1	CytokinesIBA 09/2014
1	Adenosine Monophosphate (AMP)IBA 08/2014
1	Filaggrin ProteinsIBA 08/2014
1	Antimicrobial PeptidesIBA 08/2014
1	S100 Proteins (S 100 Protein)IBA 08/2014
1	loricrinIBA 08/2014
1	Angiopoietin-2IBA 01/2014
1	Angiopoietin-1IBA 01/2014
1	Indicators and Reagents (Reagents)IBA 10/2013
1	Nicotinamide PhosphoribosyltransferaseIBA 09/2013
1	Fluorescein-5-isothiocyanate (FITC)IBA 06/2013
1	DinitrofluorobenzeneIBA 06/2013
1	Gastrin-Releasing PeptideIBA 06/2013
1	CC ChemokinesIBA 03/2013
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 03/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2013
1	Immunoglobulin E (IgE)IBA 03/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2013
1	Nerve Growth Factor (NGF)IBA 03/2013
1	angiogeninIBA 07/2012
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2012
1	EmollientsIBA 05/2012
1	ChemokinesIBA 04/2012
1	Member 14 Tumor Necrosis Factor ReceptorsIBA 04/2012
1	Interleukin-5 (Interleukin 5)IBA 04/2012
1	Interleukin-4 (Interleukin 4)IBA 04/2012
1	Interleukin-2 (IL2)IBA 04/2012
1	CyclinsIBA 03/2012
1	AllergensIBA 03/2012
1	Interleukin-17 (Interleukin 17)IBA 12/2011
1	Interleukin-22 (IL-22)IBA 12/2011
1	Interleukin-33IBA 03/2011
1	IntegrinsIBA 12/2010
1	Neutralizing AntibodiesIBA 12/2010
1	AntigensIBA 12/2010
1	Chemokine CCL11IBA 09/2010
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2009
1	anticentromere antibodyIBA 11/2008

Therapy/Procedure

1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2014
1	Aftercare (After-Treatment) 10/2012
1	Therapeutics 05/2012
1	Intraperitoneal Injections 12/2010